Buenos Aires - Conventional treatment regimens based on the use of topical and systemic retinoids and antimicrobial agents are effective in controlling the majority of cases of acne across the entire spectrum of disease severity, but there are a wide range of less commonly used modalities that can provide valuable alternatives in a number of clinical scenarios, Ana Kaminsky, M.D., Ph.D., said.
The FDA approved therapies for melanoma, dermatomyositis, superficial basal cell carcinoma, and adolescent alopecia areata, while TYK2 inhibitors and rare disease filings advanced toward 2027 decisions.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.